Extracting and purifying nucleic acids from living organisms is the first step for many critical applications for research and diagnostics. Currently, nucleic acid extraction and sample prep is a multi-step process dependent on bulky equipment and lengthy protocols with complex serious of steps that require expert labor. ANYg.BIO is developing a portable platform for automated biosample to address a critical unmet need for a $10.1B market growing at 6.4% CAGR. ANYg.BIO’s proprietary technology will enable biosample processing on-demand at the point of collection for many applications outside the lab in remote or extreme environments as well as inside standard labs.